Clinical Edge Journal Scan

Benefits of simultaneous resection of liver metastasis restricted to patients with KRAS wild-type tumors


 

Key clinical point: Simultaneous vs delayed resection of synchronous liver metastasis (SLM) was associated with longer survival rates in patients with colorectal cancer (CRC) with KRAS wild-type tumors but not in those with KRAS sequence variation.

Major finding: Perioperative complications within 60 days of surgery were not significantly different in the simultaneous vs delayed resection group ( P = .89), but simultaneous vs delayed resection was associated with better 5-year overall survival (hazard ratio [HR] 1.61; P < .001) and cancer-specific survival (HR 1.62; P = .003) in patients with KRAS wild-type tumors, but not in those with overall KRAS sequence variation.

Study details : This retrospective study included 1569 patients with CRC with or without KRAS sequence variation who underwent simultaneous (n = 512) or delayed (n = 1057) resection of SLM.

Disclosures: This study was supported by a grant from Shanghai Shenkang Clinical Science and Technology Innovation Project, China . No conflicts of interest were reported.

Source: Wu Y et al. Association of simultaneous vs delayed resection of liver metastasis with complications and survival among adults with colorectal cancer. JAMA Netw Open. 2022;5(9):e2231956 (Sep 19). Doi: 10.1001/jamanetworkopen.2022.31956

Recommended Reading

Risk-adapted screening strategy could reduce colonoscopy use
MDedge Hematology and Oncology
FDA approves futibatinib (Lytgobi) for certain biliary tract cancers
MDedge Hematology and Oncology
Is early-onset cancer an emerging global epidemic?
MDedge Hematology and Oncology
AGA Clinical Practice Update: Expert review of management of subepithelial lesions
MDedge Hematology and Oncology
AI tool may improve prediction of colorectal cancer recurrence
MDedge Hematology and Oncology
Colonoscopy in FIT-based screening demands higher ADR
MDedge Hematology and Oncology
Colonoscopy lowers CRC risk and death, but not by much: NordICC
MDedge Hematology and Oncology
Sigmoidoscopy screening cuts CRC mortality, incidence
MDedge Hematology and Oncology
One-third of pancreatic cancer diagnoses missed on scans
MDedge Hematology and Oncology
Low rectal cancer: Laparoscopic-assisted surgery safe in terms of short-term oncological outcomes
MDedge Hematology and Oncology